CCMP Exploring $1.2B Sale of Medpace

November 15, 2013 | Medpace, a CRO offering therapeutically specialized clinical development, is on the auction block according to Reuters. Private equity firm CCMP Capital Advisors owns the company and has hired an investment bank to run an auction. Medpace has top line annual earnings of close to $100 million, and CCMP believes they could earn twelve times that--$1.2 billion--in a sale. Reuters


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.